Research articlePublished 8 Mar 2019
Genetic markers in HLA region to identify patients with tuberculosis risk, in RA subjects
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Objetive: To identify the patients with RA at highest risk of TB, prior to the use of biological therapy antiTNF. Method: We carried out a study of two phases considered three groups, in the first we performed a case and control study in the Hospital Juárez de México, in the second phase, the results of phase one were analyzed with those obtained in the group of patients identified with Poncet´s disease. We compared the classes I and II of the HLA of patients naïve to biologic treatment with healthy controls. Result: We have identified several candidate alleles that will help to advance the personalized treatment of RA that takes into account the genetic risk to develop TB, particularly the alleles B27 and DQB1*0301. Conclusion: Patients with RA have an increased risk to develop TB and severe complications derived from it. This infectious process is related to the use of biologic.
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Rheumatology
- SubjectRheumatology
- BylineArticles whose byline prints “Gustavo Esteban Lugo-Zamudio”
- BylineArticles whose byline prints “Rosa Elda Barbosa-Cobos”
- BylineArticles whose byline prints “Dolores Delgado-Ochoa”
- BylineArticles whose byline prints “Rodrigo Huerta-Gutierrez & Julio Granados Arreola”